Yi Zhe Wang
Net worth: - $ as of 29/04/2024
Profile
Yi Zhe Wang served as the Chief Executive Officer & Director at LianBio from 2021 to 2023.
Prior to that, he was the Senior VP-BioMedicines & Oncology Businesses at Lilly China Research & Development Co. Ltd.
from 2018 to 2020.
Wang holds a doctorate from Yale University, an undergraduate degree from Ramapo College of New Jersey, and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIANBIO
-.--% | 09/04/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Former positions of Yi Zhe Wang
| Companies | Position | End |
|---|---|---|
| LIANBIO | Chief Executive Officer | 15/12/2023 |
Lilly China Research & Development Co. Ltd.
 Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Corporate Officer/Principal | 30/04/2020 |
Training of Yi Zhe Wang
| Yale University | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Ramapo College of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIANBIO | Health Technology |
| Private companies | 1 |
|---|---|
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Yi Zhe Wang
